Turkish ophthalmologists treat macular dystrophy using regenerative stem cell therapies and advanced photobiomodulation to slow progression. Specialists prioritize genetic testing and high-end retina workups. These protocols aim to stabilize vision in patients with Stargardt disease or macular degeneration.
- Stem cell therapy: Doctors use mesenchymal cells to stimulate and repair damaged retinal tissue environments.
- Photobiomodulation: Low-level light therapy boosts cellular energy to decrease local tissue degradation.
- Intravitreal injections: Dual-pathway therapies like Faricimab manage secondary complications such as internal fluid leakage.
- Vitrectomy surgery: Surgeons like Dr. Ahmet Satici perform complex micro-invasive procedures to repair macular architecture.
Bookimed Expert Insight: A major advantage in Turkey is the concentration of American and European board-certified specialists. For example, Dr. Peykan Türkçüoğlu trained at the Johns Hopkins Wilmer Eye Institute, and Dr. Mehmet Sahin has handled 30,000+ retinal cases. This ensures patients receive care that mirrors top US academic standards at a focused boutique clinic pace.
Patient Consensus: Patients note that getting the correct genetic diagnosis is the most important first step. Many were surprised by the detail of the retina workups, including fundus autofluorescence. They say clinics focus heavily on monitoring and vision rehabilitation to help manage daily life.
